Product
AI AGENTS
AI APPLICATIONS
OTHERS
Solutions
INDUSTRIES
Pricing
Resources
EXPLORE
ENGAGE
SUPPORT & SERVICES
About
PatSnap Eureka Platform
Agents for IP
Agents for Engineering
Agents for Life Sciences
Agents for Materials
Analytics
IP IntelligenceSynapse
Biopharma IntelligenceBio
Biosequence Search and AnalysisChemical
Chemical Structure Search and AnalysisEureka AI Inside
Professional Services
Customer Stories
Blog
Global Innovation Report
Glossary
Newsroom
Webinars & Training
Frontier
User Community
Trust and Security
PatentBench
LLM
Help center
Careers
Access to over 2,000,000,000 structured data points around patents, science, litigation, and tech sectors
Innovate 75% faster at 25% less cost
Cloud or on-prem for maximum privacy and control
Trusted by more than 18,000 innovators worldwide
To use , click the vertification button in the email we sent to [email protected].
This helps keep your account secure.
You should receive it shortly. Don’t forget to check your spam folder.
Unlock professional features and history
Already have an account? Log In
To start using PatSnap Eureka, click the verification button in the email we sent to .
This helps keep your account secure.
Haven't received it? Check your spam folder.
Thoughtfully curated series offering valuable insights for innovation professionals
Article | Report A deep-dive into the 2026 underwater glider technology landscape: buoyancy engines, hybrid propulsion, AI fleet navigation, hadal platforms, and emerging IP opportunities.
Article | Report CLDN18.2-targeted ADC and bispecific approaches in gastric and pancreatic cancer: patent landscape, clinical signals, and emerging combination strategies.
Article | Report How to push silicon anode content above 20 wt% in cylindrical 4680 cells without sacrificing cycle life — structural design, pre-lithiation, SiOx, and electrolyte strategies.
Article | Report Acoustic levitation is moving from lab curiosity to platform technology. Explore the 2026 patent landscape: phased arrays, metamaterials, biomedical applications, and IP white space.
Article | Report How to push silicon anode content above 20 wt% in cylindrical 4680 cells without sacrificing cycle life — structural design, pre-lithiation, SiOx, and binder strategies.
Article | Report Oncolytic viruses, STING agonists, and local immunostimulation: a deep-dive into the intratumoral injection drug pipeline from HSV-1 to TLR agonists.
Article | Report COF technology landscape 2026: linkage chemistry, 3D architectures, energy storage, photocatalysis, and scale-up trends mapped across 35+ patent and literature records.
Article | Report How reinforcement learning, GNNs, and surrogate AI models reduce parasitic capacitance in high-frequency analog and RF circuit layouts. 50+ patents analysed.
Article | Report How reinforcement learning, GNNs, and surrogate AI models reduce parasitic capacitance in high-frequency analog circuit design. Insights from 50+ patents.
Article | Report SHP2 inhibition combined with MEK, ERK, and KRAS G12C inhibitors is redefining treatment strategy for KRAS-driven PDAC, NSCLC, and colorectal cancer. Full pipeline analysis.
Article | Report Explore the 2026 magnetic microneedle technology landscape: patent trends, key assignees, magnetic actuation clusters, and strategic IP white spaces across 80+ records.
Article | Report A 2026 technology landscape of quantum dot infrared photodetectors (QDIPs): material systems, patent clusters, geographic activity, and emerging directions for R&D and IP strategy.
Article | Report How EUV photon shot noise, acid diffusion blur, and polymer microstructure drive LER at 3nm gate pitch — and the materials, process, and etch strategies that reduce transistor variability.
Article | Report SHP2 inhibition combined with KRAS G12C, MEK, and ERK inhibitors is reshaping treatment strategies for PDAC, NSCLC, and colorectal cancer. Explore the evidence.
Article | Report How photoresist LER drives transistor variability at 3nm gate pitch — root causes, device impact, and proven mitigation strategies from 20+ patents and papers.